Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00138788
What this trial is testing

Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases

Who this might be right for
Neoplasm MetastasisBrain Neoplasms
St George Hospital, Australia 112
Early research (Phase 1)UnknownNCT00003073
What this trial is testing

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Pacira Pharmaceuticals, Inc 15
Testing effectiveness (Phase 2)Study completedNCT00108069
What this trial is testing

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Who this might be right for
Glioma
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT02798029
What this trial is testing

Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00068666
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Alliance for Clinical Trials in Oncology 41
Not applicableLooking for participantsNCT05539677
What this trial is testing

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Who this might be right for
Malignant Solid TumorsPrimary Brain TumorMelanoma+4 more
N.N. Petrov National Medical Research Center of Oncology 1,000
Not applicableUnknownNCT03721055
What this trial is testing

Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Who this might be right for
CancerMetastatic CancerMetastatic Brain Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT00553943
What this trial is testing

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B-cell Lymphoma
Lymphoma Study Association 60
Not applicableStudy completedNCT00007007
What this trial is testing

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerRadiation Toxicity
Radiation Therapy Oncology Group 59
Not applicableStudy completedNCT04281784
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 2,512
Testing effectiveness (Phase 2)Study completedNCT00271609
What this trial is testing

Bevacizumab for Recurrent Malignant Glioma

Who this might be right for
Recurrent High-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 88
Testing effectiveness (Phase 2)Study completedNCT00005952
What this trial is testing

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more
Duke University 30
Early research (Phase 1)Study completedNCT00650923
What this trial is testing

Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)WithdrawnNCT03803761
What this trial is testing

A New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02644460
What this trial is testing

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors

Who this might be right for
Diffuse Intrinsic Pontine GliomaBrain Tumor, RecurrentSolid Tumor, Recurrent+5 more
Emory University 53
Not applicableActive Not RecruitingNCT03606161
What this trial is testing

Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors

Who this might be right for
Brain Neoplasm
M.D. Anderson Cancer Center 32
Large-scale testing (Phase 3)UnknownNCT00268684
What this trial is testing

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Tel-Aviv Sourasky Medical Center 381
Early research (Phase 1)Study completedNCT00017264
What this trial is testing

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00009854
What this trial is testing

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Direct Therapeutics
Very early researchLooking for participantsNCT06328686
What this trial is testing

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
Emory University 10
Next Page